SCHEMBL21972264

SCHEMBL21972264

COc1ccccc1C1N(C)c2cc(N(C)C)c(N(C)C)cc2N1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.53
▸ BRD4 O60885 1/20 0.41
▸ BRPF1 P55201 1/20 0.41
▸ MAP1LC3B Q9GZQ8 1/20 0.39
▸ DRD2 P14416 1/20 0.38
▸ PDGFRB P09619 1/20 0.37
▸ HTR2C P28335 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SLC6A2 P23975 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ ADRA1A P35348 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21970632 0.82 PDGFRB (0.42) LMNAPDGFRBMAPTSMN1; SMN2ALDH1A1
SCHEMBL29414076 0.82 LMNA (0.69) LMNADRD2PDGFRBHTR2CMAPT
SCHEMBL12978570 0.82 LMNA (0.69) LMNADRD2PDGFRBHTR2CMAPT
SCHEMBL21972253 0.80 PDGFRB (0.40) LMNAPDGFRBHTR2CMAPTNPSR1
SCHEMBL21970999 0.76 LMNA (0.56) LMNADRD2PDGFRBMAPTNPSR1
SCHEMBL21971403 0.75 LMNA (0.63) LMNAPDGFRBNPC1MAPTSMN1; SMN2
SCHEMBL21971009 0.75 LMNA (0.63) LMNAPDGFRBNPC1MAPTSMN1; SMN2
SCHEMBL20739824 0.74 LMNA (0.36) LMNABRD4BRPF1PDGFRBSMN1; SMN2
SCHEMBL21970984 0.74 PDGFRB (0.56) LMNAPDGFRBMAPTALDH1A1
SCHEMBL21971000 0.73 LMNA (0.49) LMNABRD4BRPF1DRD2PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046655-B2 Compound and method for producing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-06-29 — — US disclosed
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME CBR3, NR2E3, NR5A2 LMNA 4733/4885BRD4 1218/4885BRPF1 1165/4885
US-11046655-B2 Compound and method for producing same CBR3, NR5A1, NR2E3 LMNA 4570/4885BRD4 1654/4885BRPF1 1216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback